• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用大麻、可卡因、苯丙胺、摇头丸和阿片类药物的个体的死亡率:丹麦治疗中的药物使用者的全国性随访研究。

Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment.

机构信息

Unit for Psychiatric Research, Aalborg Psychiatric Hospital, Aarhus University Hospital, Aalborg,

出版信息

Drug Alcohol Depend. 2011 Apr 1;114(2-3):134-9. doi: 10.1016/j.drugalcdep.2010.09.013. Epub 2010 Oct 25.

DOI:10.1016/j.drugalcdep.2010.09.013
PMID:20971585
Abstract

This is a register-based cohort study of 20,581 individuals in treatment for illicit substance use disorders in Denmark between 1996 and 2006. All in all, 1441 deaths were recorded during 111,445 person-years of follow-up. Standardized mortality ratios (SMRs) associated with different primary substance types were calculated and Cox-regression analyses were performed in order to establish hazard ratios (HR) associated with injection drug use and psychiatric comorbidity. SMRs for primary users of specific substances were: cannabis: 4.9 (95% confidence interval (CI): 4.2-5.8), cocaine: 6.4 (CI: 3.9-10.0), amphetamine: 6.0 (CI: 4.2-8.3), heroin: 9.1 (CI: 8.5-9.8), and other opioids 7.7 (CI: 6.6-8.9). For MDMA ('ecstasy') the crude mortality rate was 1.7/1000 person-years (CI: 0.4-7.0) and the SMR was not significantly elevated. Injection drug use was associated with significantly increased hazard ratios in users of opioids and cocaine/amphetamine. Overall, psychiatric comorbidity was not associated with increased mortality (HR: 1.1 [CI: 0.9-1.2], p=.28), but an association was found specifically among cocaine/amphetamine users (HR: 3.6 [CI: 2.1-6.4], p<.001).

摘要

这是一项基于登记的队列研究,共纳入 20581 例在丹麦接受非法物质使用障碍治疗的个体,随访时间为 1996 年至 2006 年。总共记录到 1441 例死亡,随访期间的总人年数为 111445。计算了不同主要物质类型的标准化死亡率(SMR),并进行 Cox 回归分析,以确定与注射吸毒和精神共病相关的风险比(HR)。主要使用特定物质的个体的 SMR 为:大麻:4.9(95%置信区间(CI):4.2-5.8),可卡因:6.4(CI:3.9-10.0),苯丙胺:6.0(CI:4.2-8.3),海洛因:9.1(CI:8.5-9.8),其他阿片类药物 7.7(CI:6.6-8.9)。对于 MDMA(“摇头丸”),粗死亡率为 1.7/1000 人年(CI:0.4-7.0),SMR 没有显著升高。注射吸毒与阿片类药物和可卡因/苯丙胺使用者的风险比显著增加相关。总体而言,精神共病与死亡率增加无关(HR:1.1[CI:0.9-1.2],p=.28),但在可卡因/苯丙胺使用者中发现了特定的关联(HR:3.6[CI:2.1-6.4],p<.001)。

相似文献

1
Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment.使用大麻、可卡因、苯丙胺、摇头丸和阿片类药物的个体的死亡率:丹麦治疗中的药物使用者的全国性随访研究。
Drug Alcohol Depend. 2011 Apr 1;114(2-3):134-9. doi: 10.1016/j.drugalcdep.2010.09.013. Epub 2010 Oct 25.
2
Mortality following treatment for cannabis use disorders: predictors and causes.治疗大麻使用障碍后的死亡率:预测因素和原因。
J Subst Abuse Treat. 2013 Apr;44(4):400-6. doi: 10.1016/j.jsat.2012.09.007. Epub 2012 Nov 2.
3
Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment.大麻依赖治疗寻求者的精神病理学及其与后期药物滥用治疗的关联。
J Subst Abuse Treat. 2007 Mar;32(2):113-9. doi: 10.1016/j.jsat.2006.07.005. Epub 2006 Oct 27.
4
[Narcotic abuse in Jylland. A study based on narcotics and deaths of addicts examined at the Institute of Forensic Medicine, University of Aarhus during the period 1981-1988. 1. Narcotics].[日德兰半岛的麻醉品滥用情况。一项基于奥胡斯大学法医学研究所1981 - 1988年期间对麻醉品及成瘾者死亡情况进行研究的报告。1. 麻醉品]
Ugeskr Laeger. 1990 Apr 9;152(15):1077-80.
5
All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study.使用冰毒相关障碍患者的全因死亡率:一项对照队列研究。
Drug Alcohol Depend. 2012 Oct 1;125(3):290-4. doi: 10.1016/j.drugalcdep.2012.03.004. Epub 2012 Apr 13.
6
Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.精神疾病的家族易感性:大麻所致精神病和精神分裂症治疗对象的比较。
Arch Gen Psychiatry. 2008 Nov;65(11):1269-74. doi: 10.1001/archpsyc.65.11.1269.
7
Self-reported drug use and mortality among a nationwide sample of Swedish conscripts - a 35-year follow-up.全国范围内瑞典应征者样本中自我报告的药物使用与死亡率 - 35 年随访研究。
Drug Alcohol Depend. 2011 Nov 1;118(2-3):383-90. doi: 10.1016/j.drugalcdep.2011.04.025. Epub 2011 Jun 12.
8
[Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].[门诊特定环境下大麻使用者的社会人口学特征、成瘾及精神共病情况]
Encephale. 2009 Jun;35(3):226-33. doi: 10.1016/j.encep.2008.03.010. Epub 2008 Aug 19.
9
Major depression: the relative contribution of gender, MDMA, and cannabis use.重度抑郁症:性别、摇头丸使用和大麻使用的相对影响
Depress Anxiety. 2008;25(3):241-7. doi: 10.1002/da.20297.
10
[Assessment of disorders after chronic psychoactive drug abuse in patients hospitalized in detoxification units].[戒毒所住院患者慢性精神活性药物滥用后疾病的评估]
Przegl Lek. 2004;61(4):317-9.

引用本文的文献

1
Characteristics linked to mortality risk among individuals with drug use disorders enrolled in drug rehabilitation facilities in Japan.日本戒毒所中患有药物使用障碍的个体的死亡风险相关特征。
PCN Rep. 2025 May 15;4(2):e70112. doi: 10.1002/pcn5.70112. eCollection 2025 Jun.
2
Mortality among individuals with substance use disorder-does violent criminal behavior have an impact?患有物质使用障碍的个体的死亡率——暴力犯罪行为有影响吗?
Front Psychiatry. 2024 Dec 6;15:1455343. doi: 10.3389/fpsyt.2024.1455343. eCollection 2024.
3
Mortality, morbidity, and predictors of death among amphetamine-type stimulant users - a longitudinal, nationwide register study.
苯丙胺类兴奋剂使用者的死亡率、发病率及死亡预测因素——一项基于全国登记数据的纵向研究
Addict Behav Rep. 2024 May 14;19:100553. doi: 10.1016/j.abrep.2024.100553. eCollection 2024 Jun.
4
Evaluation of heroin-assisted treatment in Norway: protocol for a mixed methods study.挪威海洛因辅助治疗评估:混合方法研究方案。
BMC Health Serv Res. 2024 Mar 29;24(1):398. doi: 10.1186/s12913-024-10767-w.
5
No decline in drug overdose deaths in Norway: An ecological approach to understanding at-risk groups and the impact of interventions.挪威药物过量死亡人数未下降:一种理解高危群体及干预措施影响的生态学方法
Nordisk Alkohol Nark. 2024 Feb;41(1):111-130. doi: 10.1177/14550725231195413. Epub 2023 Sep 28.
6
Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1-aging and epigenomics.三维核结构的扰动、表观基因组失调与衰老以及大麻素突触病重新构建了大麻素病理生理学的概念:第1部分——衰老与表观基因组学。
Front Psychiatry. 2023 Sep 5;14:1182535. doi: 10.3389/fpsyt.2023.1182535. eCollection 2023.
7
Advancing cross-sectoral data linkage to understand and address the health impacts of social exclusion: Challenges and potential solutions.推进跨部门数据链接,以了解和应对社会排斥对健康的影响:挑战与潜在解决方案。
Int J Popul Data Sci. 2023 Jun 7;8(1):2116. doi: 10.23889/ijpds.v8i1.2116. eCollection 2023.
8
A Six-Year Follow-up of People Who Use Cannabis in Iran - A Case Series.伊朗大麻使用者的六年随访——病例系列
Addict Health. 2023 Jan;15(1):71-76. doi: 10.34172/ahj.2023.1357. Epub 2023 Jan 29.
9
Cannabis- and Substance-Related Carcinogenesis in Europe: A Lagged Causal Inferential Panel Regression Study.欧洲大麻及物质相关致癌作用:一项滞后因果推断面板回归研究
J Xenobiot. 2023 Jul 18;13(3):323-385. doi: 10.3390/jox13030024.
10
Mortality during and after specialist alcohol and other drug treatment: Variation in rates according to principal drug of concern and treatment modality.在接受专科酒精和其他药物治疗期间和之后的死亡率:根据主要关注药物和治疗方式的不同,死亡率有所变化。
Drug Alcohol Rev. 2023 Sep;42(6):1461-1471. doi: 10.1111/dar.13669. Epub 2023 Apr 25.